Longeveron Announces Resignation of Board Members
Longeveron Inc. announced the immediate resignation of Board members Mr. Khoso Baluch and Ms. Neha Motwani, effective November 7, 2025. Their resignations were not due to disagreements with the company. The current analyst rating for Longeveron (LGVN) stock is a Hold with a price target of $0.50. Spark's AI Analyst rates LGVN as Neutral, citing significant financial challenges, declining revenues, and negative profitability, despite some positive developments in clinical trials. The company's market cap is $15.82M with bearish technical sentiment.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Longeveron ( (LGVN) ) just unveiled an update.
On November 7, 2025, Longeveron Inc. announced the immediate resignation of Mr. Khoso Baluch and Ms. Neha Motwani from its Board of Directors. Their departures were not due to any disagreements with the company’s operations, policies, or management, suggesting a smooth transition without internal conflict.
The most recent analyst rating on (LGVN) stock is a Hold with a $0.50 price target. To see the full list of analyst forecasts on Longeveron stock, see the LGVN Stock Forecast page.
Spark’s Take on LGVN Stock
According to Spark, TipRanks’ AI Analyst, LGVN is a Neutral.
Longeveron’s overall stock score reflects significant financial and operational challenges, with declining revenues and negative profitability being the most impactful factors. Technical analysis indicates bearish momentum, and valuation metrics highlight substantial risk. While the earnings call provided some positive developments in clinical trials, financial risks remain a major concern.
To see Spark’s full report on LGVN stock, click here.
More about Longeveron
Average Trading Volume: 794,246
Technical Sentiment Signal: Sell
Current Market Cap: $15.82M
